- In April 2025, Sartorius AG launched a next-generation line of automated single-use fermenters designed to streamline biopharmaceutical manufacturing. These systems feature enhanced scalability, integrated monitoring, and AI-driven process controls to optimize cell culture conditions and improve batch-to-batch consistency in vaccine and biologic production
- In March 2025, Eppendorf AG introduced a new series of benchtop fermenters tailored for research and small-scale production. The BioBLU® c-series fermenters offer modular flexibility, advanced aeration control, and compatibility with a wide range of microorganisms, supporting innovation in academic, industrial, and synthetic biology labs
- In February 2025, Thermo Fisher Scientific Inc. announced the expansion of its fermenter production facility in Massachusetts, aiming to meet surging demand from pharmaceutical and food industries. The expansion includes increased capacity for stainless-steel and hybrid fermenters with integrated data analytics to support GMP-compliant manufacturing
- In January 2025, Bioengineering AG unveiled a new continuous stirred tank fermenter (CSTR) optimized for the production of industrial enzymes and probiotics. Featuring real-time pH and DO control, this fermenter enhances yield efficiency and supports sustainable production practices for functional food and feed applications
- In January 2025, GEA Group AG partnered with a leading Asian biotechnology firm to co-develop large-scale photo fermenters for use in the production of algae-based nutritional and cosmetic ingredients. The collaboration aims to leverage solar bio-reactor technology for energy-efficient, high-yield biomass cultivation
